Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Experimental Oncology
  • Published:

Evaluation of a morpholinothiolporphyrin for use in photodynamic therapy

Abstract

The photonecrotic effectiveness of a morpholinothiolporphyrin derived from haematoporphyrin was measured in an animal model of cerebral glioma. The dose administered was 20 mg kg-1 and the laser dose varied from 0 to 200 J cm-2. The tumour necrosis was at least as good as that of HpD, and this therapeutic response may be attributed to the targeting of specific 'photopotent' subcellular sites.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Woodburn, K., Hill, J., Stylli, S. et al. Evaluation of a morpholinothiolporphyrin for use in photodynamic therapy. Br J Cancer 70, 398–400 (1994). https://doi.org/10.1038/bjc.1994.316

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1994.316

This article is cited by

Search

Quick links